Most notable was the CHMP giving a positive opinion for the new gene therapy Breyanzi (lisocabtagene maraleucel), from US pharma major Bristol ...
https://www.google.com/url?rct=j&sa=t&url=https://www.thepharmaletter.com/article/january-new-medicines-approval-recommendations-from-ema-chmp&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFhHLHuL0tOZFvxjjuOH_Rxjgeb_g
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.